GlobeNewswire Inc | Aug 12, 2021 08:00AM EDT

August 12, 2021

Reports Second Quarter Revenue of $6.3 Million on Diversified Product Sales

Company Continues to grow ENVG-B Night Vision, Medical and International Programs

HOPEWELL JUNCTION, N.Y., Aug. 12, 2021 (GLOBE NEWSWIRE) -- eMagin Corporation, or the Company, (NYSE American: EMAN), a leader in the development, design and manufacture of Active Matrix OLED microdisplays for high-resolution, AR/VR and other near-eye imaging products, today announced results for its quarter ended June 30, 2021.

We continue to make steady progress in developing our Direct Patterning Display (dPd) technology and remain on schedule to produce disruptive and industry-leading, high-brightness, high-resolution, and full-color prototypes this year, said eMagin CEO Andrew G. Sculley. We believe our improvements in the OLED architecture and dPd processes will meet the performance goals of our tier-one OEM customers using the high-resolution backplanes we have developed for them. As a further testament to our technological leadership, several new patents were issued and allowed in the second quarter, which are centered on improvements to the dPd process for improved yield and device performance.

In addition to improvements in dPd materials and processes, we have advanced the state of the art with our XLE technology, which utilizes a white OLED emitter with color filters. This technology provides customers with a substantial gain in luminance and/or power savings for their applications. We have already closed a major design win with a military customer to use these displays and are currently ramping production. We will enhance the technology over the next year to provide even greater luminance improvement to our customers, a critical need for the military, medical and commercial AR/VR solutions of tomorrow. We believe our parallel strategy of disrupting the industry with direct patterning combined with improvements in the color filter roadmap will enable us to continue to lead the high brightness at lower power roadmap and drive the AR/VR applications of the future.

In the second quarter, we continued to see uptake of our technology into new applications, including new head-mounted display programs, undersea connected-diver products, and new thermal weapon scopes. The thermal scope business continued to show a strong recovery in post-pandemic order growth. We believe that as XLE and dPd mature, we will accelerate our growth of new technology insertions.

In terms of revenue, our second-quarter results were mixed, with continued display revenue growth in our ENVG-B program, and increased shipments to medical, veterinary and hunting scope customers. However, our year-over-year decrease in total revenue reflected the impact of production issues and unexpected manufacturing tool downtime in the quarter. As we continue to bring on new equipment as part of our $39.1 million Title III and IBAS programs, we expect to resolve these issues. Our contract revenue decreased year over year mainly due to the timing of certain development work for a tier-one consumer customer. Overall, as of June 30, 2021, our sales backlog of open orders was $10.3 million, which grew to $16.0 million by July 31, 2021.

Second Quarter Results

Total revenues for the second quarter of 2021 were $6.3million, compared with $7.7million reported in the prior-year period.

Total revenue consists of both product revenue and contract revenue. Product revenues for the second quarter of 2021 were $5.7million, a decrease of $0.5million from product revenues of $6.3million reported in the prior-year period. The year-over-year decrease in display revenue primarily resulted from unexpected downtime experienced with manufacturing equipment, which delayed certain display shipments into the third quarter. The decline was partially offset by higher sales to military, medical and veterinary customers. Contract revenues were $0.5million, compared with $1.4 million reported in the prior year, reflecting the timing of phases and milestones associated with the contract of a tier-one consumer company. eMagin is continuing to work on a proof of concept and anticipates ongoing contract revenue with this customer.

Total gross margin for the second quarter was 9% on gross profit of $0.6million, compared with a gross margin of 26% on gross profit of $2.0million in the prior-year period. The decrease in gross margin reflects decreased shipments of displays in the three months ended June30, 2021, combined with the impact of lower manufacturing volumes and decreases in period costs capitalized into inventory due to equipment issues that occurred during the second quarter of 2021.

Operating expenses for the second quarter of 2021, including R&D expenses, were $3.5million, compared with $3.3million in the prior-year period. Operating expenses as a percentage of sales were 55% in the second quarter of 2021 compared with 43% in the prior-year period. The year-over-year increase in R&D reflects materials and other overhead costs related to development and qualification of the Companys higher brightness XLE and dPd displays, and a decrease in costs allocated to contracts reflecting lower contract revenues in the 2021 period.

Operating loss for the second quarter of 2021 was $2.9million, compared with an operating loss of $1.3million in the prior-year period, reflecting the decreased gross profit and increased investments in R&D in the current year.

Net loss for the second quarter of 2021 was $0.3 million, or $0.00 per share, compared with a loss of $2.8 million, or $0.05 per share, in the prior year period. Net loss for the current period includes a $2.6 million non-cash profit related to the change in fair value of a warrant liability. Excluding the impact of the change in the fair value of the warrant liability for both periods, net loss for the second quarter of 2021 was $2.9 million, or $0.04 per share, versus a net loss of $1.3 million, or $0.02 per share in the prior-year period.

Adjusted EBITDA for the second quarter of 2021 was negative $2.0million, compared with negative $0.8million in the prior-year period.

Balance Sheet Highlights

As of June30, 2021, the Company had cash and cash equivalents of $10.6million and working capital of $9.0million. During the second quarter, the Company borrowed $0.2 million under its asset-based lending (ABL) facility and realized proceeds from the exercise of stock options and warrants of $1.0 million. Borrowings and availability under the ABL facility were $0.4million and $1.9million, respectively, as of June30, 2021.

During the quarter eMagin took delivery of two additional production tools, which will improve the reliability of our processes and improve yields. We continue to make down payments with vendors that are building equipment requested under the Companys government capital equipment funding awards.

Measurement of Inventory

As previously announced, in recognition of a shift in product demand toward larger, more complex displays yielding fewer die per wafer, the Company determined that measuring output by the number of displays produced per quarter is not an accurate measure of production capacity, and that measuring output based on the number of wafers produced per quarter is a more appropriate measure of production volume. As the number of wafers produced per quarter has remained consistent for the past two years, the Company concluded it was no longer in a period of abnormal production that would require limiting the amount of overheads allocated to inventory. The Company believes that fully allocating the overhead to work in process and finished goods inventories results in more accurate inventory valuation and computation of costs of goods sold, in addition to providing better information for making pricing decisions.

Under this change in estimate for allocating overhead, which was adopted in the first quarter of 2021, overhead is now fully allocated to products, resulting in an increase in standard costs and decrease inventory values. In the second quarter of 2021, the impact of this change was a decrease of approximately $0.2 million in the carrying value of the Companys work in process and finished goods inventory, with a corresponding decrease in product cost of goods sold.

Chief Financial Officer

In July, eMagins board of directors formally named Mark Koch as chief financial officer. Mr. Koch had served as the Companys acting CFO since January of 2020.

Conference Call and Webcast Information

Management will host a conference call and simultaneous webcast at 9 a.m. ET on Thursday, August 12 to discuss eMagins quarterly results, business highlights and outlook. To join the live listen-only webcast, please visit the Companys Investor Relations website at https://www.emagin.com/investors/events. To join the conference call, dial 1-844-308-1725 in the United States, or 1-929-517-0939 internationally. The entry code is 2481588. Participants are encouraged to join at least 10 minutes before the start of the call. An archive of the webcast will be available approximately one hour after the live call.

About eMagin Corporation

eMagin is the leader in OLED microdisplay technology for the next generation of computing and imaging devices, serving world-class customers in the military, consumer, medical and industrial markets. The Company invents, engineers and manufactures display technologies of the future and is the only manufacturer of OLED displays in the United States. eMagin's Direct Patterning Technology (dPd) will transform the way the world consumes information. Since 2001, eMagin's microdisplays have been used in AR/VR, aircraft helmets, heads-up display systems, thermal scopes, night vision goggles, future weapon systems and a variety of other applications. For more information, please visit www.emagin.com.

Important Cautionary Information Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding eMagin Corporation's expectations, intentions, strategies and beliefs pertaining to future events or future financial performance. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors, including those described in the Company's most recent filings with the SEC. For a more complete description of the risk factors that could cause our actual results to differ from our current expectations, including impacts of the COVID-19 pandemic, please see the section entitled "Risk Factors" in eMagin's Annual Report on Form 10-K for the fiscal year ended December31, 2020, and in any Form 10-Q filed or to be filed by eMagin, and in other documents we file with the SEC from time to time.

ContacteMagin CorporationMark A. KochChief Financial Officer845-838-7900investorrelations@emagin.com

Sharon Merrill Associates, Inc. Nicholas ManganaroVice President617-542-5300eman@investorrelations.com

eMAGIN CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands, except share data)(Unaudited)

June30, December31, 2021 2020ASSETS Current assets: Cash and cash equivalents $ 10,568 $ 8,315 Restricted cash 1,491 2,111 Accounts receivable, net 3,117 5,314 Account receivable-due from government awards 77 1,013 Unbilled accounts receivable 783 253 Inventories 8,133 8,379 Prepaid expenses and other current assets 795 943 Total current assets 24,964 26,328 Property, plant and equipment, net 25,517 21,132 Operating lease right - of - use assets 21 50 Intangibles and other assets 121 126 Total assets $ 50,623 $ 47,636 LIABILITIES AND SHAREHOLDERS? EQUITY Current liabilities: Accounts payable $ 1,425 $ 1,206 Accrued compensation 2,346 1,628 Paycheck Protection Program loan - current ? 982 Revolving credit facility, net 405 1,875 Common stock warrant liability 9,188 4,622 Other accrued expenses 559 1,693 Deferred revenue 86 425 Operating lease liability - current 21 51 Finance lease liability - current 1,129 1,027 Other current liabilities 825 757 Total current liabilities 15,984 14,266 Other liability - long term 42 56 Paycheck Protection Program loan - long term ? 982 Deferred Income - government awards - long term 7,935 4,309 Finance lease liability - long term 11,631 11,783 Total liabilities 35,592 31,396 Shareholders? equity: Preferred stock, $.001 par value: authorized 10,000,000 shares:Series B Convertible Preferred stock, (liquidationpreference of $5,659) stated value $1,000 pershare, $.001 par value: 10,000 shares designated ? ? and 5,659 issued and outstanding as of June 30,2021 and December 31, 2020.Common stock, $.001 par value: authorized200,000,000 shares, issued 72,665,730 shares,outstanding 72,503,664 shares as of June 30, 2021 72 69 and issued 68,890,819 shares, outstanding68,728,753 shares as of December 31, 2020.Additional paid-in capital 275,173 268,729 Accumulated deficit (259,714 ) (252,058 )Treasury stock, 162,066 shares as of June 30, 2021 (500 ) (500 )and December 31, 2020.Total shareholders? equity 15,031 16,240 Total liabilities and shareholders? equity $ 50,623 $ 47,636

eMAGIN CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(Unaudited)

Three Months Ended Six Months Ended June30, June30, 2021 2020 2021 2020Revenues: Product $ 5,742 $ 6,260 $ 11,847 $ 11,894 Contract 537 1,440 1,205 2,537 Total 6,279 7,700 13,052 14,431 revenues, net Cost of revenues: Product 5,466 4,978 10,173 9,768 Contract 242 746 600 1,253 Total cost of 5,708 5,724 10,773 11,021 revenues Gross profit 571 1,976 2,279 3,410 Operating expenses: Research and 1,788 1,599 3,630 2,579 developmentSelling,general and 1,690 1,712 3,514 3,510 administrativeTotaloperating 3,478 3,311 7,144 6,089 expenses Loss from (2,907 ) (1,335 ) (4,865 ) (2,679 )operations Other(expense) income:Change in fairvalue ofcommon stock 2,642 (1,481 ) (4,566 ) (1,501 )warrantliabilityInterest (205 ) (18 ) (415 ) (35 )expense, netGain onforgiveness of ? ? 1,963 ? debtOther income, 192 3 227 15 netTotal other 2,629 (1,496 ) (2,791 ) (1,521 )(expense)Loss beforeprovision for (278 ) (2,831 ) (7,656 ) (4,200 )income taxesIncome taxes ? ? ? ? Net loss $ (278 ) $ (2,831 ) $ (7,656 ) $ (4,200 )Less netincomeallocated to ? ? ? ? participatingsecuritiesNet lossallocated to $ (278 ) $ (2,831 ) $ (7,656 ) $ (4,200 )common shares Loss pershare, basic $ ? $ (0.05 ) $ (0.11 ) $ (0.08 )and diluted Weightedaverage number of sharesoutstanding: Basic and 72,193,205 56,754,867 71,238,060 54,196,732 Diluted

Non-GAAP Financial Measures

To supplement the Companys consolidated financial statements presented on a GAAP basis; the Company has provided non-GAAP financial information, namely earnings before interest, taxes, depreciation and amortization, and non-cash compensation expense (Adjusted EBITDA). The Companys management believes that this non-GAAP measure provides investors with a better understanding of how the results relate to the Companys historical performance. The additional adjusted information is not meant to be considered in isolation or as a substitute for GAAP financial statements. Management believes that these adjusted measures reflect the essential operating activities of the Company. A reconciliation of non-GAAP financial information appears below (in thousands).

Three Months Ended Six Months Ended June30, June30, 2021 2020 2021 2020 Net loss $ (278 ) $ (2,831 ) $ (7,656 ) $ (4,200 )Non-cash 37 44 50 87 compensationChange in fairvalue of common (2,642 ) 1,481 4,566 1,501 stock warrantliabilityDepreciationand intangibles 694 479 1,427 959 amortizationexpenseInterest 205 18 415 35 expenseAdjusted EBITDA $ (1,984 ) $ (809 ) $ (1,198 ) $ (1,618 )